PixCell Medical Technologies news

PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, today announced the opening of a United States subsidiary in the Denver metropolitan area. The new office will increase logistical and commercial support for PixCell`s U.S. clients and will handle order fulfilment across the country, as well as provide additional clinical and technical support to customers.

"Opening a U.S. office is a s

PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, today announced it has signed an exclusive distribution agreement with medical diagnostics company Gamidor Diagnostics to distribute the HemoScreen™, PixCell`s hematology analyzer, across Israel. This deal follows a global shift spurred by the COVID-19 pandemic towards near-patient, digitally con

PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that Soulbrain Holdings has acquired all controlling PixCell shares, as well as investing in the company, making Soulbrain the majority shareholder of PixCell Medical. The acquisition of PixCell aligns with Soulbrain`s recent strategic transition into the healthcare and in-vitro diagn

PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, today announced an exclusive distribution agreement with Axonlab, a leader in point-of-care testing in Europe providing the healthcare sector with equipment and services in the fields of medical diagnostics, life science, and software solutions, to distribute the HemoScreen™

PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that the Risk Underlying Rural Areas Longitu

PixCell Medical, innovator of rapid diagnostic solutions at the point-ofcare, today announced a partnership with Aidian, a Finland-based in-vitro diagnostics company providing reliable, fast, and easy-to-use diagnostic tests for primary care. Aidian will serve as the sole distributor of PixCell’s HemoScreen™, a hematology analyzer designed for use at the point of care, with exclusive distribution rights in Finland, Norway, Denmark, Latvia and Estonia.

“Offering cost-

PixCell Medical, innovator of rapid diagnostic solutions at the point-ofcare, today announced a partnership with Triolab, the largest diagnostics distributor in the Nordic and Baltic countries, to be the sole distributor in Sweden of the HemoScreen™, PixCell’s hematology analyzer designed for use at the point of care.

“PixCell’s HemoScreen brings lab-quality haematology results closer to the patient, making it possible to analyze Complete Blood Count (CBC) with

PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that The Journal of Applied Laboratory Medicine (JALM) has published a research paper comparing PixCell`s HemoScreen™ and its analysis method to standard lab analyzers. Researchers concluded that PixCell`s HemoScreen™, a miniature, easy-to-use, AI and machine vision-enabled hematolog

PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that it has received regulatory approval from the Australian Therapeutic Goods Administration (TGA) for the HemoScreen™, PixCell`s hematology analyzer that offers a 5-part differential CBC intended for point-of-care (POC) use. Under the TGA approval, PixCell`s HemoScreen is cleared for use with adults and infants alike, from as early as 2 mon

PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that it has signed a distribution agreement with Point of Care Diagnostics Aus. Pty Ltd (POCD), supplier and distributor of point-of-care testing solutions to Australasia, making POCD the sole regional distributor of the HemoScreen™, a small-sized, simple-to-operate diagnostic platform designed for point-of-care use.

“We recognize the need to simplify real-time blood testing and